Reversible angiotensin II-mediated albuminuria in rat kidneys is dynamically associated with cytoskeletal organization

Nephron

Volumn 93, Issue 2, 2003, Pages

  Clavant, Steven P ^a   Forbes, Josephine M ^b   Thallas, Vicki ^b   Osicka, Tanya M ^b   Jerums, George ^b   Comper, Wayne D ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Albumin fractional clearance; Angiotensin II; Glomerular permeability

Indexed keywords

ALBUMIN; ALPHA TUBULIN; ANGIOTENSIN; BIURET; IMMUNOGLOBULIN G; ANGIOTENSIN II; PLASMA PROTEIN; TUBULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSKELETON; GLOMERULUS FILTRATION; IMMUNOCHEMISTRY; KIDNEY; KIDNEY CLEARANCE; KIDNEY TUBULE; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEINURIA; RADIOACTIVITY; RADIOIMMUNOASSAY; RAT; STATISTICAL ANALYSIS; TISSUE PERFUSION; ALBUMINURIA; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IN VITRO STUDY; INFUSION PUMP; KINETICS; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE; URINE;

ALBUMINURIA; ANGIOTENSIN II; ANIMALS; BLOOD PROTEINS; CYTOSKELETON; IMMUNOHISTOCHEMISTRY; INFUSION PUMPS; KIDNEY; KIDNEY TUBULES; KINETICS; MALE; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; TUBULIN;

EID: 0037264706     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068528     Document Type: Article

References (39)

1. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: The Collaborative Study Group. N Engl J Med 1993;329:1456-1462.
2. Parving HH, Rossing P, Hommel E, Smidt UM: Angiotensin-converting enzyme inhibition in diabetic nephropathy: Ten years' experience. Am J Kid Dis 1995;26:99-107.
3. Cooper ME: Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998;352:213-219.
4. Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH: Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int 2000;57:601-606.
5. Bakris GL, Weir MR, DeQuattro V, McMahon FG: Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney Int 1998;54:1283-1289.
6. Nakamura T, Obata J, Kimura H, Ohn S, Yoshida Y, Kawachi H, Shimizu F: Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 1999;55:877-889.
7. Anderson S, Jung FF, Ingelfinger JR: Renal renin-angiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations. Am J Physiol 1993;265:F477-F486.
8. Cheng H-F, Burns KD, Harris RC: Reduced proximal tubule angiotensin II receptor expression in streptozotocin-induced diabetes mellitus. Kidney Int 1994;46:1603-1610.
9. Anderson S: Role of local and systemic angiotensin in diabetic renal disease. Kidney Int 1997;52(suppl 63):S107-S110.
10. Wolf G, Ziyadeh FN: The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 1997;29:153-163.
11. Cheng H-F, Becker BN, Burns KD, Harris RC: Angiotensin II upregulates type-I angiotensin II receptors in renal proximal tubule. J Clin Invest 1995;95:2012-2019.
12. Navar LG, Harrison-Bernard LM, Wang C, Cervenka CL, Mitchell KD: Concentrations and actions of intraluminal angiotensin II. J Am Soc Nephrol 1999;10:S189-S195.
13. Allen AM, Zhuo J, Mendelsohn FAO: Localization of angiotensin AT1 and AT2 receptors. J Am Soc Nephrol 1999;10:S23-S29.
14. Einsbach GM, Van Liew JB, Boylan JW: Effect of angiotensin on the filtration of protein in the rat kidney: A micropuncture study. Kidney Int 1975;8:80-87.
15. Bohrer MP, Deen WM, Robertson CR, Brenner BM: Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol 1977;233:F13-F21.
16. Loon N, Shemesh O, Morelli E, Myers BD: Effect of angiotensin II infusion on the human glomerular filtration barrier. Am J Physiol 1989;257:F608-F614.
17. 2]-angiotensin II in rats. Biol Pharm Bull 1994;17:1516-1518.
18. Lapinski R, Perico N, Remuzzi A, Sangalli F, Benigni A, Remuzzi G: Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. J Am Soc Nephrol 1996;7:653-660.
19. Osicka TM, Pratt LM, Comper WD: Glomerular capillary wall permeability to albumin and horseradish peroxidase. Nephrology 1996;2:199-212.
20. Kellerman PS, Bogusky RT: Microfilament disruption occurs very early in ischemic proximal tubule cell injury. Kidney Int 1992;42:896-902.
21. Abbate M, Bonventre JV, Brown D: The microtubule network of renal epithelial cells is disrupted by ischemia and reperfusion. Am J Physiol 1994;267:F971-F978.
22. Radermacher J, Klanke B, Kastner S, Haake G, Schurek H-J, Stolte HF, Frölich JC: Effect of arginine depletion on glomerular and tubular kidney function: Studies in isolated perfused rat kidneys. Am J Physiol 1991;261:F779-F786.
23. Shanley PF, Brezis M, Spokes K, Silva P, Epstein FH, Rosen S: Hypoxic injury in the proximal tubule of the isolated perfused rat kidney. Kidney Int 1986;29:1021-1032.
24. Burne MJ, Adal Y, Cohen N, Panagiotopoulos S, Jerums G, Comper WD: Anomalous decrease in dextran sulfate clearance in the diabetic rat kidney. Am J Physiol 1998;274:F700-F708.
25. Eppel GA, Nagy S, Jenkins MA, Tudball RN, Daskalakis M, Balazs NDH, Comper WD: Variability of standard clinical protein assays in the analysis of a model urine solution of fragmented albumin. Clin Biochem 2000;33:487-494.
26. Greive KA, Nikolic-Paterson DJ, Guimarães MAM, Nikolovski J, Pratt LM, Mu W, Atkins RC, Comper WD: Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis. Am J Path 2001;159:1159-1170.
27. Gornall AG, Bardawill CJ, David MM: Determination of serum proteins by means of the Biuret reaction. J Biol Chem 1949;177:751-766.
28. Tack BF, Dean J, Eilat D, Lorenz PE, Schecter AN: Tritium labelling of proteins to high specific radioactivity by reductive methylation. J Biol Chem 1980;255:8842-8847.
29. Van Damme M-P, Comper WD, Preston BN: Experimental measurements of polymer unidirectional fluxes in polymer + solvent systems with non-zero chemical potential gradients. J Chem Soc Faraday Trans I 1982;78:3357-3367.
30. 14C: Protein A, a long-lived immunological reagent. J Immunol Meth 1985;81:239-243.
31. Boyce NW, Holdsworth SR: Glomerular permselectivity in the isolated perfused rat kidney. Am J Physiol 1985;249:F780-F784.
32. Burne MJ, Osicka TM, Comper WD: Fractional clearance of high molecular weight proteins on conscious rats using a continuous infusion method. Kidney Int 1995;55:261-270.
33. Wiig H, De Carlo M, Sibley L, Renkin EM: Interstitial exclusion of albumin in rat tissues measured by continuous infusion method. Am J Physiol 1992;263:H1222-H1233.
34. 131I-labeled human growth hormone of high specific radioactivity. Biochem J 1963;89:114-123.
35. Eppel GA, Osicka TM, Pratt LM, Jablonski P, Howden BO, Glasgow EF, Comper WD: The return of glomerular-filtered albumin to the rat renal vein. Kidney Int 1999;55:1861-1870.
36. Osicka TM, Kiriazis Z, Pratt LM, Jerums G, Comper WD: Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats. Diabetologia 2001;44:230-236.
37. Wapstra FH, Navis GJ, van Goor H, van den Born J, Berden JH, de Jong PE, de Zeeuw D: ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy. Exp Nephrol 2001;9:21-27.
38. Mifsud SA, Allen TJ, Bertram JF, Hulthen UL, Kelly DJ, Cooper ME, Wilkinson-Berka JL, Gilbert RE: Podocyte foot process broadening in experimental diabetic nephropathy: Amelioration with renin-angiotensin blockade. Diabetologia 2001;44:878-882.
39. Gekle M, Mildenberger S, Freudinger R, Schwerdt G, Silbernagl S: Albumin endocytosis in OK cells: Dependence on actin and microtubules and regulation by protein kinases. Am J Physiol 1997;272:F668-F677.